ENvue Medical (FEED) Net Cash Flow (2014 - 2026)

ENvue Medical (FEED) has reported Net Cash Flow for 13 consecutive years, with -$1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 132.46% year-over-year to -$1.1 million in Q2 2026; TTM through Jun 2026 was -$2.9 million, a 253.73% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, up 239.08% from the prior year.
• Net Cash Flow was -$1.1 million for Q2 2026 at ENvue Medical, up from -$2.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $3.5 million in Q3 2023 and troughed at -$2.7 million in Q4 2025.
• A 5-year average of -$476333.3 and a median of -$993500.0 in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow jumped 723.96% in 2025 and sank 1226.0% in 2026, its largest moves.
• Over 5 years, Net Cash Flow stood at -$1.3 million in 2022, then jumped by 63.08% to -$491000.0 in 2023, then fell by 11.61% to -$548000.0 in 2024, then plunged by 398.72% to -$2.7 million in 2025, then soared by 58.87% to -$1.1 million in 2026.
• The last three Net Cash Flow figures came in at -$1.1 million (Q2 2026), -$2.0 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.